The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials
Open accessAbstract
Background Using latent class analysis (LCA), in five randomized control trial (RCT) cohorts, two distinct phenotypes of ARDS have been identified (hypo-inflammatory and hyper-inflammatory). The phenotypes are associated with differential outcomes and treatment response. The objective of this project was to develop parsimonious classifier models for phenotype identification that could be accurate and feasible to use in the clinical setting. Methods In this retrospective study, three ARDS network RCT cohorts (ARMA, ALVEOLI, and FACTT) were used as the derivation dataset (N=2022), and a fourth (SAILS) was used as the validation dataset (N=715). LCA-derived phenotypes in all of these cohorts served as the reference standard. Machine-learning algorithms were used to select important classifier variables, which were then used to develop nested logistic regression models. The best logistic regression models based on parsimony and predictive accuracy were then evaluated in the validation dataset. Finally, the models’ prognostic validity was tested in two external ARDS clinical trial datasets (START and HARP-2). Findings The six most important classifier variables were IL-8, IL-6, protein C, soluble TNF-receptor-1, bicarbonate, and vasopressor-use. From the nested models, 3-variable (IL-8, bicarbonate, and protein C) and 4-variable models (3-variable plus vasopressor use) were adjudicated to be the best performing. In the validation cohort, both models showed good accuracy (AUC 0·94; 95% CI: 0·92–0·95 and 0·95; 95% CI: 0·93–0·96 respectively). In the external datasets, 3-variable models developed in the derivation dataset identified two phenotypes with distinct clinical features and outcomes consistent with prior findings, including differential survival with simvastatin in HARP-2. Interpretation ARDS phenotypes can be accurately identified with simple classifier models using 3–4 variables. Pending the development of real-time testing for key biomarkers and prospective validation, these models could facilitate identification of ARDS phenotypes to enable their application in clinical trials and practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Prone positioning in severe acute respiratory distress syndrome.
Guérin, C., Reignier, J., Richard, J.-C., Beuret, P., Gacouin, A., Boulain, T., Mercier, E., Badet, M., Mercat, A., Baudin, O., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214103 · Cited by 4,040 · cited 2×
“Randomized, placebo‐controlled clinical trial of an aerosolized beta(2)‐ agonist for treatment of acute lung injury.”
BackgroundComparison of Two Fluid-Management Strategies in Acute Lung Injury
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062200 · Cited by 3,538
Permutation importance: a corrected feature importance measure
Altmann, A., Toloşi, L., Sander, O., & Lengauer, T. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq134 · Cited by 2,843
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa032193 · Cited by 2,565
Calfee, C. S., Delucchi, K., Parsons, P. E., Thompson, B. T., Ware, L. B., & Matthay, M. A. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70097-9 · Cited by 1,544
Self-citationFamous, K. R., Delucchi, K., Ware, L. B., Kangelaris, K. N., Liu, K. D., Thompson, B. T., & Calfee, C. S. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201603-0645oc · Cited by 820
Self-citationCalfee, C. S., Delucchi, K. L., Sinha, P., Matthay, M. A., Hackett, J., Shankar-Hari, M., McDowell, C., Laffey, J. G., O'Kane, C. M., McAuley, D. F., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30177-2 · Cited by 748
Self-citationMatthay, M. A., Calfee, C. S., Zhuo, H., Thompson, B. T., Wilson, J. G., Levitt, J. E., Rogers, A. J., Gotts, J. E., Wiener-Kronish, J. P., Bajwa, E. K., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30418-1 · Cited by 600
Self-citationRosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome
The National Heart, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401520 · Cited by 537
Cited by
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes
Bos, L. D. J., & Ware, L. B. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01485-4 · Cited by 1,025
Grasselli, G., Calfee, C. S., Camporota, L., Poole, D., Amato, M. B. P., Antonelli, M., Arabi, Y. M., Baroncelli, F., Beitler, J. R., Bellani, G., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07050-7 · Cited by 953
Self-citationLeisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V., Mastroiani, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 855
Self-citationA New Global Definition of Acute Respiratory Distress Syndrome
Matthay, M. A., Arabi, Y., Arroliga, A. C., Bernard, G., Bersten, A. D., Brochard, L. J., Calfee, C. S., Combes, A., Daniel, B. M., Ferguson, N. D., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202303-0558ws · Cited by 812
Self-citationSardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 592
Metadata
- Authors
- Sinha, P., Delucchi, K. L., McAuley, D. F., O'Kane, C. M., Matthay, M. A., & Calfee, C. S.
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 8
- Issue
- 3
- Pages
- 247-257
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W2998886261
- Cited by
- 307
- References
- 22
- FWCI
- 18.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. https://app.cochat.ai/papers/10.1016/s2213-2600(19)30369-8
- The paper
- Sinha, P., Delucchi, K. L., McAuley, D. F., O'Kane, C. M., Matthay, M. A., & Calfee, C. S. (2020). Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(19)30369-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.